By the same authors

From the same journal

Prominin-1 (CD133) Expression in the Prostate and Prostate Cancer: A Marker for Quiescent Stem Cells

Research output: Contribution to journalArticle

Published copy (DOI)



Publication details

JournalAdvances in experimental medicine and biology
DatePublished - 2013
Number of pages18
Pages (from-to)167-84
Original languageEnglish


The origin and phenotype of stem cells in human prostate cancer remains a subject of much conjecture. In this scenario, CD133 has been successfully used as a stem cell marker in both normal prostate and prostate cancer. However, cancer stem cells have been identified without the use of this marker, opening up the possibility of a CD133 negative cancer stem cell. In this chapter, we review the current literature regarding prostate cancer stem cells, with specific reference to the expression of CD133 as a stem cell marker to identify and purify stem cells in normal prostate epithelium and prostate cancer.

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations